Tenax Therapeutics Inc

General ticker "TENX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $120.1M

Tenax Therapeutics Inc does not follow the US Stock Market performance with the rate: -19.0%.

Estimated limits based on current volatility of 2.2%: low 5.40$, high 5.65$

Factors to consider:

  • Current price 64.7% below estimated low
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [46.13$, 203.76$]
  • 2023-12-31 to 2024-12-30 estimated range: [15.54$, 64.90$]

Financial Metrics affecting the TENX estimates:

  • Negative: Non-GAAP EPS, $ of -529.73 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -74.76 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
  • Negative: 0.14 < Interest expense per share, $ of 0.24

Similar symbols

Short-term TENX quotes

Long-term TENX plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $9.87MM $32.73MM $11.05MM
Operating Income $-9.87MM $-32.73MM $-11.05MM
Non-Operating Income $0.02MM $0.25MM $0.00MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $4.56MM $25.15MM $5.38MM
Income(Loss) $-9.85MM $-32.47MM $-11.05MM
Profit(Loss) $-9.85MM $-32.47MM $-11.05MM
Stockholders Equity $4.63MM $4.24MM $1.49MM
Assets $6.87MM $5.99MM $3.40MM
Operating Cash Flow $-9.27MM $-10.86MM $-12.01MM
Capital expenditure $0.00MM $0.01MM $0.00MM
Investing Cash Flow $0.02MM $0.45MM $-0.00MM
Financing Cash Flow $10.60MM $9.74MM $8.55MM
Earnings Per Share* $-1,523.80 $-2,545.11 $-600.46

* EPS are Split Adjusted, recent splits may be reflected with a delay.